EPIVX | VIHAX | EPIVX / VIHAX | |
Total Expense Ratio | 1.73 | 0.17 | 1,018% |
Annual Report Gross Expense Ratio | 1.73 | 0.17 | 1,018% |
Fund Existence | 15 years | 9 years | - |
Gain YTD | 12.163 | 9.401 | 129% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 142M | 8.85B | 2% |
Annual Yield % from dividends | 1.62 | 4.45 | 36% |
Returns for 1 year | 16.73 | 8.69 | 193% |
Returns for 3 years | 18.61 | 12.64 | 147% |
Returns for 5 years | 97.56 | 78.80 | 124% |
Returns for 10 years | 58.66 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HEGD | 21.70 | -0.31 | -1.41% |
Swan Hedged Equity US Large Cap ETF | |||
ROMO | 30.02 | -0.59 | -1.93% |
Strategy Shares Nwfnd/RSlv Rbt Mmt ETF | |||
IEMG | 53.16 | -1.11 | -2.05% |
iShares Core MSCI Emerging Markets ETF | |||
BUFD | 24.39 | -0.71 | -2.83% |
FT Vest Laddered Deep Buffer ETF | |||
AESR | 15.92 | -0.87 | -5.21% |
Anfield US Equity Sector Rotation ETF |